Bodycote (LON:BOY – Get Free Report) announced its quarterly earnings results on Tuesday. The company reported GBX 18.10 earnings per share for the quarter, Digital Look Earnings reports. Bodycote had a return on equity of 9.30% and a net margin of 7.87%.
Here are the key takeaways from Bodycote’s conference call:
- Strong first-half performance: Core organic revenue grew 9.6%, led by Aerospace & Defense, industrial gas turbines and a recovery in medical, more than offsetting a 4.4% decline in automotive. Adjusted EPS increased 18.3% to £0.252.
- Group operating margin improved 110 basis points to 16%, supported by the Optimise restructuring program, lower-cost operations and reduced exposure to low-margin non-core activities. Management expects further Optimise benefits and volume leverage in the second half.
- Optimise remains on track, with 29 of 31 planned footprint actions expected to be completed by year-end and at least £15 million of annualized benefits targeted by mid-2027. The company is evaluating a further phase focused mainly on structurally challenged automotive operations, but acknowledged that returns may be less attractive than in the initial phase.
- Full-year guidance was reaffirmed, although second-half growth is expected to moderate because of tougher comparisons and core margins remain subject to variable-pay normalization and new-site investment costs. Capital expenditure is expected near the lower end of the previously guided £80 million–£90 million range, while the company continues its £80 million buyback and selective M&A strategy.
Bodycote Trading Down 0.6%
Shares of BOY stock opened at GBX 719.50 on Thursday. The firm has a 50-day moving average price of GBX 715.13 and a 200 day moving average price of GBX 713.23. Bodycote has a twelve month low of GBX 585 and a twelve month high of GBX 850. The company has a market capitalization of £1.22 billion, a price-to-earnings ratio of 23.21, a PEG ratio of 1.44 and a beta of 1.35. The company has a current ratio of 1.12, a quick ratio of 0.74 and a debt-to-equity ratio of 35.03.
Key Bodycote News
- Positive Sentiment: Bodycote reported quarterly earnings of GBX 18.10 per share, alongside a 9.30% return on equity and 7.87% net margin. While no year-on-year or consensus comparison was provided, the results offer investors evidence of continued profitability. Bodycote quarterly earnings report
- Positive Sentiment: Deutsche Bank reaffirmed its Buy rating and set a GBX 960 price target, implying meaningful upside relative to the recent trading level. Digital Look broker views
- Positive Sentiment: Jefferies and Berenberg also maintained Buy recommendations, each with a GBX 900 target, reinforcing broadly positive sell-side sentiment. Digital Look broker views
- Positive Sentiment: Bodycote’s shares moved above their 200-day moving average, a technical signal that can attract momentum-oriented investors and suggest improving market sentiment. Bodycote share price moves above 200-day moving average
- Neutral Sentiment: Royal Bank of Canada reaffirmed a Sector Perform rating with a GBX 750 target, indicating a more cautious view than the other brokers and limiting the strength of the consensus signal. Digital Look broker views
Analyst Upgrades and Downgrades
A number of equities research analysts recently commented on BOY shares. Berenberg Bank reissued a “buy” rating and issued a GBX 900 price objective on shares of Bodycote in a research note on Wednesday. Jefferies Financial Group reaffirmed a “buy” rating and issued a GBX 900 price target on shares of Bodycote in a report on Wednesday. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and issued a GBX 960 price target on shares of Bodycote in a research report on Wednesday. Finally, Royal Bank Of Canada restated a “sector perform” rating and set a GBX 750 price objective on shares of Bodycote in a research report on Wednesday. Four investment analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of GBX 842.50.
Read Our Latest Research Report on Bodycote
About Bodycote
The leading provider of heat treatment and specialist thermal processing services worldwide.
Heat treatment encompasses a variety of techniques and specialist engineering processes which improve the properties of metals and alloys and extend the life of components and is a vital part of any manufacturing process.
Bodycote is uniquely placed via our global network and the experience and knowledge of our people to offer high quality, reliable and cost-effective services to manufacturers whatever their size or market sector.
Featured Stories
- Five stocks we like better than Bodycote
- Why SK hynix Could Be the Best AI Chip Stock to Buy Now
- Seagate Technology Stock Surges as Earnings Beat Silences AI Doubters
- Alphabet Is Down 18% From Its High After a Stellar Quarter—Overdone, or More Downside Ahead?
- Why Bloom Energy May Be the Most Important AI Infrastructure Stock
Receive News & Ratings for Bodycote Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bodycote and related companies with MarketBeat.com's FREE daily email newsletter.
